BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 25, 2014
View Archived Issues
alpha-Amino-beta-lactam carbamates as systemic NAAA inhibitors
Read More
Researchers describe the function of MS susceptibility gene
Read More
New synthetic anti-TB drug from a rediscovered natural cyclic peptide
Read More
Newly identified genetic variations linked to riboflavin-responsive MADD disorder
Read More
Ajinomoto presents new MGAT2 inhibitors for obesity and dyslipidemia
Read More
Cynata licenses rights to Cellular Dynamics iPSC line for use with Cymerus technology
Read More
Merck & Co. presents results for MK-0674 in ovariectomized cynomolgus monkeys
Read More
Oxabact awarded E.U. orphan drug designation for short bowel syndrome
Read More
Viable mouse models of methylmalonic acidemia created
Read More
New agents for HCV infection disclosed by Idenix Pharmaceuticals
Read More
Allergan patents novel antibiotic conjugates for ocular disorders
Read More
Elusys Therapeutics completes phase III program for inhalational anthrax antibody
Read More
Convergence Pharmaceuticals achieves clinical proof of concept for CNV-1014802
Read More
Jiva Pharma synthesize new ascorbate esters of omega-3
Read More
TG Therapeutics exercises license option for TGR-1202
Read More
Merck KGaA to acquire Sigma-Aldrich
Read More
MedImmune's MEDI-3902 receives FDA fast track designation
Read More
Epirus reports 58-week follow-up data for infliximab biosimilar
Read More
Novavax reports data for H7N9 avian influenza VLP vaccine candidate
Read More
FDA approves Otezla for the oral treatment of plaque psoriasis
Read More
FDA awards fast track designation to aramchol for NASH
Read More
Gilead seeks Japanese approval for ledipasvir/sofosbuvir for genotype 1 HCV
Read More
Tekmira joins international consortium for clinical trials in Ebola
Read More
FibroGen reports 1-year data supporting the safety and efficacy profile of FG-3019
Read More
Endpoints met in phase III studies of secukinumab for psoriatic arthritis
Read More
Rexahn's RX-3117 awarded U.S. orphan drug designation for pancreatic cancer
Read More
